CIK 0001661181
- Accelerated filer
Organogenesis Holdings Inc.
Sign in to watch- Ticker
- ORGO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 781-575-0775
- Business address
- 85 DAN ROAD, CANTON, MA, 02021
- Former names
- Avista Healthcare Public Acquisition Corp.
- 4 Exercise or conversion VP Health Policy & Contracting acquired 30,450 shares (option exercise)
- 4 Exercise or conversion Chief Commercial Officer acquired 1,817 shares (option exercise)
- 4 Open-market buy Director bought 542,349 shares at an average $3.98 ($2,160,957)
- 4 Exercise or conversion President and CEO acquired 397,900 shares (option exercise)
- 4 Open-market buy Director bought 6,000,000 shares at $5.00 ($30,000,000)
- 4 Open-market buy 10% owner bought 3,603 shares at $6.00 ($21,618)
- 4 Open-market buy Director bought 4,990 shares at an average $6.13 ($30,570)
- 4 Open-market buy Director bought 860,900 shares at an average $5.99 ($5,155,772)
- 4 Open-market buy Director bought 13,010 shares at an average $5.30 ($69,017)
- 4 Open-market buy Director bought 537,000 shares at an average $5.18 ($2,782,529)
- 4 Open-market buy Director bought 10,000 shares at $5.03 ($50,274)
- 4 Open-market buy Director bought 10,000 shares at $5.03 ($50,274)
- 4 Open-market buy Director bought 5,000 shares at $4.20 ($21,000)
- 4 Open-market buy Director bought 82,000 shares at an average $4.47 ($366,211)
- 4 Open-market buy 10% owner bought 10,000 shares at $4.50 ($44,975)
- 4 Open-market buy Director bought 105,100 shares at an average $4.50 ($473,209)
- 4 Open-market buy Director bought 105,100 shares at an average $4.50 ($473,209)
- 4 Open-market buy Director bought 577,600 shares at an average $4.84 ($2,797,551)
- 4 Grant or award Director acquired 389,501 shares (grant or award)
- 4 Derivatives Options or other derivatives
Page 13 of 17 · 321 filings